Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Klinik Health Ventures was a Canadian capital pool company formed to identify and complete a qualifying transaction in the healthcare sector. It completed its initial public offering in December 2019 on the TSX Venture Exchange under the symbol KHV.P. In March 2020, the company announced a qualifying transaction with 2576560 Ontario Inc., operating as NeuPath Health, a provider of chronic pain management services. On June 25, 2020, the transaction closed through a reverse takeover and the company changed its name to NeuPath Health Inc. As a result, Klinik Health Ventures did not operate a standalone drug development pipeline; its principal significance is as the predecessor public entity to NeuPath Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Klinik Health Ventures.